FTCHF yields 666666.67% · JNJ yields 2.14%● Live data
📍 FTCHF pulled ahead of the other in Year 1
Combined, FTCHF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FTCHF + JNJ for your $10,000?
Farfetch Limited, together with its subsidiaries, operates a platform for the luxury fashion industry in the United States, the United Kingdom, and internationally. It operates through three segments: Digital Platform, Brand Platform, and In-Store. The company operates The Farfetch Marketplace, a global digital luxury fashion marketplace that connects consumers from approximately 190 countries and territories with merchandise from sellers, including brands, boutiques and department stores; New Guards, a platform that designs, manufactures, and distributes luxury fashion brands; Browns, a fashion and luxury goods retailer; Stadium Goods, a premium sneaker and streetwear marketplace and retailer; and VioletGrey.com, Luxclusif, Farfetch Future Retail, and other online sales channel. It also offers Farfetch Platform Solutions comprising building and operation of e-commerce and technology solutions for luxury brands and retailers; and ancillary services, including digital marketing, production, and customer services. In addition, the company operates Browns, Stadium Goods, Violet Grey, Off-White, Palm Angels, Ambush, and other brand stores; and Farfetch app. Further, the company engages in the web design, build, development, and retail distribution for retailers and brands. Farfetch Limited was founded in 2007 and is headquartered in London, the United Kingdom.
Full FTCHF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.